Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)
Xtant Medical Holdings' (XTNT) quarterly Restructuring Costs came in at -$1.0 million in Q4 2018, down 130.88% year-on-year from $3.3 million in Q4 2017, and down 265.15% on a QoQ basis from $614000.0 in Q3 2018.
Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018) Analysis & Trends
Xtant Medical Holdings (XTNT) has 2 years of Restructuring Costs data on file, last reported at -$1.0 million in Q4 2018.
- On a quarterly basis, Restructuring Costs fell 130.88% year-over-year to -$1.0 million in Q4 2018; TTM through Dec 2018 was $1.6 million, a 72.55% decrease from a year earlier, with the FY2018 full-year figure at $1.6 million, down 66.5% from the prior year.
- Restructuring Costs for Q4 2018 stood at -$1.0 million, down from $614000.0 in the prior quarter.
- Over the last five years, Restructuring Costs for XTNT reached as high as $3.3 million in Q4 2017 and fell as low as -$1.0 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.01 Mn |
| Sep 30, 2018 | 614,000.00 |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 733,000.00 |
| Dec 31, 2017 | 3.28 Mn |
| Sep 30, 2017 | 792,000.00 |
| Jun 30, 2017 | 1.63 Mn |